Showing results (191-200 of 200) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
The New England Journal of Medicine|June 2, 2025
Perioperative Durvalumab in Gastric and Gastroesophageal Junction CancerYelena Y Janjigian, Salah-Eddin Al-Batran, Zev A Wainberg, et al.European Journal of Cancer (Oxford, England : 1990)|February 22, 2017
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative GroupAntonio Irigoyen, Javier Gallego, Carmen Guillén Ponce, et al.British Journal of Cancer|August 3, 2017
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer RegistryPaula Jiménez Fonseca, Alberto Carmona-Bayonas, Raquel Hernández, et al.Viruses|June 28, 2023
Hantavirus in Panama: Twenty Years of Epidemiological Surveillance ExperienceBlas Armién, Carlos Muñoz, Hector Cedeño, et al.Nature Communications|February 15, 2017
A genome-wide association study yields five novel thyroid cancer risk lociJulius Gudmundsson, Gudmar Thorleifsson, Jon K Sigurdsson, et al.Nature Genetics|October 4, 2011
Mutations in BRIP1 confer high risk of ovarian cancerThorunn Rafnar, Daniel F Gudbjartsson, Patrick Sulem, et al.Nature Genetics|January 24, 2012
Discovery of common variants associated with low TSH levels and thyroid cancer riskJulius Gudmundsson, Patrick Sulem, Daniel F Gudbjartsson, et al.Plos Biology|April 13, 2011
Global human footprint on the linkage between biodiversity and ecosystem functioning in reef fishesCamilo Mora, Octavio Aburto-Oropeza, Arturo Ayala Bocos, et al.Human Molecular Genetics|May 28, 2014
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancerThorunn Rafnar, Patrick Sulem, Gudmar Thorleifsson, et al.Nature Genetics|September 28, 2011
A germline variant in the TP53 polyadenylation signal confers cancer susceptibilitySimon N Stacey, Patrick Sulem, Aslaug Jonasdottir, et al.Pageof 20